Labetalol
Overview
Labetalol (HCl) is oral and parenteral competitive cocdirselective ß -adrenergic and selective postsynaptic a-1 adrenergic receptor blocker. Due to the presence of two optical centers, there are four diastereoisomers of labetolol, each of which displays different relative activities. The drug mixture possesses three to seven times greater ß -blocking activity than a-1 -blocking activity. Labetalol is clinically used in the treatment of hypertension associated with a variety of conditions. Labetalol was approved by the FDA for use in August 1984. Labetalol (HCl) is a reversible ß blocker with concurrent a1 blocking actions that produces peripheral vasodialation.lt blocks ß1-receptors in the heart, ß 2-receptors in bronchial and vascular smooth muscle, and a 1receptors in vascular smooth muscle. The ß-blocking activity is three to seven times as potent as the a-blocking ability.The result of labetalol's actions at a- and ß-receptors leads to vasodilation and decreased total peripheral resistance, which results in decreased blood pressure without a substantial decrease in resting heart rate, cardiac output, or stroke volume
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Labetalol's dosage details are as follows:
Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
10 to 20 mg | 15 (15) | As recommended. | | With increasements of 5 to 10 mg if satisfactory hypotension is not acheived after 5 minutes. |
15 to 20 mg/hr | 18 (17.5) | As recommended. | Iv infusion | Initial rate & gradually increased to a dose of 120 mg/hr in hypertention after myocardial infection & 160 mg for hypertension hour in pregnancy. |
100 to 200 mg | 150 (150) | As recommended. | oral | Twice per day. |
100 mg | 100 (100) | 12 hourly | oral | Initially with food. |
2.85 to 34.28 mg/kg | 19 (18.565) | As recommended. | PO | As Required |
Paedriatic Dosage (20kg)
|
0.5 to 0 mg/kg/hour | 0.25 (0.25) | As recommended. | | To maximum of 3mg/kg/hour,For 1 month to 12 years. |
30 to 0 mg/hour | 15 (15) | As recommended. | | 12-18 years. |
Neonatal Dosage (3kg)
|
No data regarding the neonatal dosage details of Labetalol is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Labetalol
Back to top
Previous Drug Generic - Next Drug Generic